دورية أكاديمية

Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial

التفاصيل البيبلوغرافية
العنوان: Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
المؤلفون: Shinde, Vivek *, Cho, Iksung, Plested, Joyce S, Agrawal, Sapeckshita, Fiske, Jamie, Cai, Rongman, Zhou, Haixia, Pham, Xuan, Zhu, Mingzhu, Cloney-Clark, Shane, Wang, Nan, Zhou, Bin, Lewis, Maggie, Price-Abbott, Patty, Patel, Nita, Massare, Michael J, Smith, Gale, Keech, Cheryl, Fries, Louis, Glenn, Gregory M
المصدر: In The Lancet Infectious Diseases January 2022 22(1):73-84
قاعدة البيانات: ScienceDirect
الوصف
تدمد:14733099
DOI:10.1016/S1473-3099(21)00192-4